Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Return on Sales (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Return on Sales for 9 consecutive years, with 0.51% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 36.0% to 0.51% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.16% through Dec 2025, up 9.0% year-over-year, with the annual reading at 0.16% for FY2025, 9.0% up from the prior year.
  • Return on Sales hit 0.51% in Q4 2025 for Inspire Medical Systems, up from 0.04% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.51% in Q4 2025 to a low of 0.4% in Q1 2021.
  • Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.04% in 2021.
  • Biggest five-year swings in Return on Sales: skyrocketed 165bps in 2021 and later fell -7bps in 2025.
  • Year by year, Return on Sales stood at 0.03% in 2021, then soared by 176bps to 0.02% in 2022, then soared by 236bps to 0.08% in 2023, then surged by 91bps to 0.15% in 2024, then skyrocketed by 244bps to 0.51% in 2025.
  • Business Quant data shows Return on Sales for INSP at 0.51% in Q4 2025, 0.04% in Q3 2025, and 0.02% in Q2 2025.